{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:15:42Z","timestamp":1790950542928,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Reserve Talent Development Project of Kunming Health Science and Technology","award":["2022-SW [Reserve Talents]-006"],"award-info":[{"award-number":["2022-SW [Reserve Talents]-006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>QuantiFERON-TB Gold Plus (QFT-Plus) is an important test that has emerged in recent years for detecting TB infection. We conducted a review to compare the sensitivity, specificity and positive rate of QFT-Plus with that of QuantiFERON-TB Gold In-Tube (QFT-GIT), T-cell spot of tuberculosis assay (T-SPOT.TB) and Tuberculin test (TST).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      PubMed and Embase were searched, without language restrictions, from 1 January 2015 to 31 March 2022 using \u201c\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      Infections\u201d and \u201cQuantiFERON-TB-Plus\u201d as search phrases. We estimated the sensitivity from studies of patients with active tuberculosis, specificity from studies of populations with very low risk of TB exposure, and positive rate from studies of high-risk populations. The methodological quality of the eligible studies was assessed, and a random-effects model meta-analysis was used to determine the risk difference (RD). We assessed the pooled rate by using a random-effects model. This study was registered in PROSPERO (CRD 42021267432).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 3996 studies, 83 were eligible for full-text screening and 41 were included in the meta-analysis. In patients with active TB, the sensitivity of QFT-Plus was compared to that of QFT-GIT and T-SPOT.TB, respectively, and no statistically differences were found. In populations with a very low risk of TB exposure, the specificity of QFT-Plus was compared with that of QFT-GTI and T-SPOT.TB, respectively, and no statistically differences were found. Two studies were eligible to compare the specificity of the QFT-Plus test with that of the TST test, and the pooled RD was 0.12 (95% CI 0.02 to 0.22). In high-risk populations, 18 studies were eligible to compare the positive rate of the QFT-Plus test with that of the QFT-GIT test, and the pooled RD was 0.02 (95% CI 0.01 to 0.03). The positive rate of QFT-Plus was compared with that of T-SPOT.TB and TST groups, and no statistically differences were found.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The diagnostic performance of QFT-Plus was similar to that of QFT-GIT and T-SPOT.TB, but was slightly more specific than TST.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08008-2","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T11:05:48Z","timestamp":1674212748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Comparing the diagnostic performance of QuantiFERON-TB Gold Plus with QFT-GIT, T-SPOT.TB and TST: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Defu","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"key":"8008_CR1","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.01163-21","volume":"9","author":"AG Costa","year":"2021","unstructured":"Costa AG, Carvalho BKS, Ara\u00fajo-Pereira M, Ibiapina HNS, Spener-Gomes R, Souza AB, et al. Lessons learned from implementation of an interferon gamma release assay to screen for latent tuberculosis infection in a large multicenter observational cohort study in Brazil. Microbiol Spectr. 2021;9: e0116321.","journal-title":"Microbiol Spectr"},{"key":"8008_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RM Houben","year":"2016","unstructured":"Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 2016;13: e1002152.","journal-title":"PLoS Med"},{"key":"8008_CR3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/heapol\/czaa122","volume":"35","author":"L L\u00f3pez","year":"2020","unstructured":"L\u00f3pez L, Keynan Y, Marin D, R\u00edos-Hincapie CY, Montes F, Escudero-Atehortua AC, et al. Is tuberculosis elimination a feasible goal in Colombia by 2050? Health Policy Plan. 2020;35:47\u201357.","journal-title":"Health Policy Plan"},{"key":"8008_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12916-015-0341-4","volume":"13","author":"GH Huynh","year":"2015","unstructured":"Huynh GH, Klein DJ, Chin DP, Wagner BG, Eckhoff PA, Liu R, et al. Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease. BMC Med. 2015;13:88.","journal-title":"BMC Med"},{"key":"8008_CR5","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1098\/rsif.2007.1138","volume":"5","author":"C Dye","year":"2008","unstructured":"Dye C, Williams BG. Eliminating human tuberculosis in the twenty-first century. J R Soc Interface. 2008;5:653\u201362.","journal-title":"J R Soc Interface"},{"key":"8008_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12879-017-2301-4","volume":"17","author":"P Auguste","year":"2017","unstructured":"Auguste P, Tsertsvadze A, Pink J, Court R, McCarthy N, Sutcliffe P, et al. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis. BMC Infect Dis. 2017;17:200.","journal-title":"BMC Infect Dis"},{"key":"8008_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.autrev.2008.07.011","volume":"8","author":"A Lalvani","year":"2008","unstructured":"Lalvani A, Millington KA. Screening for tuberculosis infection prior to initiation of anti-TNF therapy. Autoimmun Rev. 2008;8:147\u201352.","journal-title":"Autoimmun Rev"},{"key":"8008_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188631","volume":"12","author":"TN Doan","year":"2017","unstructured":"Doan TN, Eisen DP, Rose MT, Slack A, Stearnes G, McBryde ES. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: a latent-class analysis. PLoS ONE. 2017;12: e0188631.","journal-title":"PLoS ONE"},{"key":"8008_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.advms.2019.09.001","volume":"64","author":"B Pourakbari","year":"2019","unstructured":"Pourakbari B, Mamishi S, Benvari S, Mahmoudi S. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon-\u03b3 release assays: a systematic review and meta-analysis. Adv Med Sci. 2019;64:437\u201343.","journal-title":"Adv Med Sci"},{"key":"8008_CR10","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.jiac.2020.06.019","volume":"26","author":"K Takeda","year":"2020","unstructured":"Takeda K, Nagai H, Suzukawa M, Sekiguchi R, Akashi S, Sato R, et al. Comparison of QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold In-Tube, and T-SPOT.TB among patients with tuberculosis. J Infect Chemother. 2020;26:1205\u201312.","journal-title":"J Infect Chemother"},{"key":"8008_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106508","volume":"185","author":"F Viana Machado","year":"2021","unstructured":"Viana Machado F, Morais C, Santos S, Reis R. Evaluation of CD8(+) response in QuantiFERON-TB Gold Plus as a marker of recent infection. Respir Med. 2021;185: 106508.","journal-title":"Respir Med"},{"key":"8008_CR12","doi-asserted-by":"publisher","first-page":"e01950-19","DOI":"10.1128\/JCM.01950-19","volume":"58","author":"A Shafeque","year":"2020","unstructured":"Shafeque A, Bigio J, Hogan CA, Pai M, Banaei N. Fourth-generation QuantiFERON-TB Gold Plus: what is the evidence? J Clin Microbiol. 2020;58:e01950-19.","journal-title":"J Clin Microbiol"},{"key":"8008_CR13","doi-asserted-by":"publisher","first-page":"e1116","DOI":"10.1093\/cid\/ciaa1822","volume":"73","author":"CE Oh","year":"2021","unstructured":"Oh CE, Ortiz-Brizuela E, Bastos ML, Menzies D. Comparing the diagnostic performance of QuantiFERON-TB Gold Plus to other tests of latent tuberculosis infection: a systematic review and meta-analysis. Clin Infect Dis. 2021;73:e1116\u201311125.","journal-title":"Clin Infect Dis"},{"key":"8008_CR14","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","volume":"46","author":"H Getahun","year":"2015","unstructured":"Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J. 2015;46:1563\u201376.","journal-title":"Eur Respir J"},{"key":"8008_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m549","volume":"368","author":"JR Campbell","year":"2020","unstructured":"Campbell JR, Winters N, Menzies D. Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis. BMJ. 2020;368: m549.","journal-title":"BMJ"},{"key":"8008_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529\u201336.","journal-title":"Ann Intern Med"},{"key":"8008_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jclinepi.2007.03.016","volume":"61","author":"TH Hamza","year":"2008","unstructured":"Hamza TH, van Houwelingen HC, Stijnen T. The binomial distribution of meta-analysis was preferred to model within-study variability. J Clin Epidemiol. 2008;61:41\u201351.","journal-title":"J Clin Epidemiol"},{"key":"8008_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h4718","volume":"351","author":"P Sedgwick","year":"2015","unstructured":"Sedgwick P, Marston L. How to read a funnel plot in a meta-analysis. BMJ. 2015;351: h4718.","journal-title":"BMJ"},{"key":"8008_CR19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"8008_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22:153\u201360.","journal-title":"Evid Based Ment Health"},{"key":"8008_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.tube.2017.06.002","volume":"106","author":"E Petruccioli","year":"2017","unstructured":"Petruccioli E, Vanini V, Chiacchio T, Cuzzi G, Cirillo DM, Palmieri F, et al. Analytical evaluation of QuantiFERON-Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis. Tuberculosis. 2017;106:38\u201343.","journal-title":"Tuberculosis"},{"key":"8008_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jinf.2019.01.007","volume":"78","author":"MR Lee","year":"2019","unstructured":"Lee MR, Chang CH, Chang LY, Chuang YC, Sun HY, Wang JT, et al. CD8 response measured by QuantiFERON-TB Gold Plus and tuberculosis disease status. J Infect. 2019;78:299\u2013304.","journal-title":"J Infect"},{"key":"8008_CR23","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/j.jiac.2021.08.016","volume":"27","author":"K Fukushima","year":"2021","unstructured":"Fukushima K, Kubo T, Akagi K, Miyashita R, Kondo A, Ehara N, et al. Clinical evaluation of QuantiFERON\u00ae-TB Gold Plus directly compared with QuantiFERON\u00ae-TB Gold In-Tube and T-Spot\u00ae.TB for active pulmonary tuberculosis in the elderly. J Infect Chemother. 2021;27:1716\u201322.","journal-title":"J Infect Chemother"},{"key":"8008_CR24","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.21037\/jtd.2019.12.11","volume":"11","author":"JY Hong","year":"2019","unstructured":"Hong JY, Park SY, Kim A, Cho SN, Hur YG. Comparison of QFT-Plus and QFT-GIT tests for diagnosis of M. tuberculosis infection in immunocompetent Korean subjects. J Thorac Dis. 2019;11:5210\u20137.","journal-title":"J Thorac Dis"},{"key":"8008_CR25","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.jiac.2021.08.003","volume":"27","author":"JK Lee","year":"2021","unstructured":"Lee JK, Lee HW, Heo EY, Yim JJ, Kim DK. Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube tests for patients with active and latent tuberculosis: a prospective cohort study. J Infect Chemother. 2021;27:1694\u20139.","journal-title":"J Infect Chemother"},{"key":"8008_CR26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.5588\/ijtld.17.0721","volume":"22","author":"DJ Horne","year":"2018","unstructured":"Horne DJ, Jones BE, Kamada A, Fukushima K, Winthrop KL, Siegel SAR, et al. Multicenter study of QuantiFERON(\u00ae)-TB Gold Plus in patients with active tuberculosis. Int J Tuberc Lung Dis. 2018;22:617\u201321.","journal-title":"Int J Tuberc Lung Dis"},{"key":"8008_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3904\/kjim.2019.002","volume":"35","author":"SH Kim","year":"2020","unstructured":"Kim SH, Jo KW, Shim TS. QuantiFERON-TB Gold PLUS versus QuantiFERON- TB Gold In-Tube test for diagnosing tuberculosis infection. Korean J Intern Med. 2020;35:383\u201391.","journal-title":"Korean J Intern Med"},{"key":"8008_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jiac.2017.10.009","volume":"24","author":"J Takasaki","year":"2018","unstructured":"Takasaki J, Manabe T, Morino E, Muto Y, Hashimoto M, Iikura M, et al. Sensitivity and specificity of QuantiFERON-TB Gold Plus compared with QuantiFERON-TB Gold In-Tube and T-SPOT.TB on active tuberculosis in Japan. J Infect Chemother. 2018;24:188\u201392.","journal-title":"J Infect Chemother"},{"key":"8008_CR29","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.cmi.2016.05.006","volume":"22","author":"H Hoffmann","year":"2016","unstructured":"Hoffmann H, Avsar K, G\u00f6res R, Mavi SC, Hofmann-Thiel S. Equal sensitivity of the new generation QuantiFERON-TB Gold plus in direct comparison with the previous test version QuantiFERON-TB Gold IT. Clin Microbiol Infect. 2016;22:701\u20133.","journal-title":"Clin Microbiol Infect"},{"key":"8008_CR30","doi-asserted-by":"publisher","first-page":"540","DOI":"10.4269\/ajtmh.18-0674","volume":"100","author":"AW Kay","year":"2019","unstructured":"Kay AW, DiNardo AR, Dlamini Q, Kahari J, Mndzebele T, Mtetwa G, et al. Evaluation of the QuantiFERON-Tuberculosis Gold Plus assay in children with tuberculosis disease or following household exposure to tuberculosis. Am J Trop Med Hyg. 2019;100:540\u20133.","journal-title":"Am J Trop Med Hyg"},{"key":"8008_CR31","doi-asserted-by":"publisher","first-page":"30617","DOI":"10.1038\/srep30617","volume":"6","author":"L Yi","year":"2016","unstructured":"Yi L, Sasaki Y, Nagai H, Ishikawa S, Takamori M, Sakashita K, et al. Evaluation of QuantiFERON-TB Gold Plus for detection of Mycobacterium tuberculosis infection in Japan. Sci Rep. 2016;6:30617.","journal-title":"Sci Rep"},{"key":"8008_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13496","volume":"33","author":"S S\u00fcr\u00fcc\u00fco\u011flu","year":"2020","unstructured":"S\u00fcr\u00fcc\u00fco\u011flu S, T\u00fcrelErmertcan A, \u00c7etinarslan T, \u00d6zk\u00fct\u00fck N. The reliability of tuberculin skin test in the diagnosis of latent tuberculosis infection in psoriasis patients: a case\u2013control study. Dermatol Ther. 2020;33: e13496.","journal-title":"Dermatol Ther"},{"key":"8008_CR33","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/ppul.25173","volume":"56","author":"E B\u00f6nc\u00fco\u011flu","year":"2021","unstructured":"B\u00f6nc\u00fco\u011flu E, K\u0131ymet E, \u015eahinkaya \u015e, Akaslan Kara A, \u00c7a\u011flar \u0130, Ar\u0131kan K, et al. Usefulness of screening tests for diagnosis of latent tuberculosis infection in children. Pediatr Pulmonol. 2021;56:1114\u201320.","journal-title":"Pediatr Pulmonol"},{"key":"8008_CR34","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.5588\/ijtld.20.0153","volume":"24","author":"H Zhang","year":"2020","unstructured":"Zhang H, Cao X, Wang D, Xin H, Liu Z, Yan J, et al. The acquisition of Mycobacterium tuberculosis infection in village doctors in China: a prospective study. Int J Tuberc Lung Dis. 2020;24:1241\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"key":"8008_CR35","doi-asserted-by":"publisher","first-page":"e00438","DOI":"10.1128\/JCM.00438-18","volume":"56","author":"MR Ryu","year":"2018","unstructured":"Ryu MR, Park MS, Cho EH, Jung CW, Kim K, Kim SJ, et al. Comparative evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in diagnosis of latent tuberculosis infection in immunocompromised patients. J Clin Microbiol. 2018;56:e00438\u2013518.","journal-title":"J Clin Microbiol"},{"key":"8008_CR36","doi-asserted-by":"publisher","first-page":"e01854","DOI":"10.1128\/JCM.01854-19","volume":"58","author":"D Won","year":"2020","unstructured":"Won D, Park JY, Kim HS, Park Y. Comparative results of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus assays for detection of tuberculosis infection in clinical samples. J Clin Microbiol. 2020;58:e01854\u2013919.","journal-title":"J Clin Microbiol"},{"key":"8008_CR37","doi-asserted-by":"publisher","first-page":"e00985","DOI":"10.1128\/JCM.00985-19","volume":"57","author":"TK Venkatappa","year":"2019","unstructured":"Venkatappa TK, Punnoose R, Katz DJ, Higgins MP, Banaei N, Graviss EA, et al. Comparing QuantiFERON-TB Gold Plus with other tests to diagnose Mycobacterium tuberculosis infection. J Clin Microbiol. 2019;57:e00985-e01019.","journal-title":"J Clin Microbiol"},{"key":"8008_CR38","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01870-21","volume":"10","author":"Y Xu","year":"2022","unstructured":"Xu Y, Yang Q, Zhou J, Zhou F, Hezhang Y, Gao Y, et al. Comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in the diagnosis of Mycobacterium tuberculosis infections in immunocompromised patients: a real-world study. Microbiol Spectr. 2022;10: e0187021.","journal-title":"Microbiol Spectr"},{"key":"8008_CR39","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1128\/JCM.02498-16","volume":"55","author":"HW Moon","year":"2017","unstructured":"Moon HW, Gaur RL, Tien SS, Spangler M, Pai M, Banaei N. Evaluation of QuantiFERON-TB Gold-Plus in health care workers in a low-incidence setting. J Clin Microbiol. 2017;55:1650\u20137.","journal-title":"J Clin Microbiol"},{"key":"8008_CR40","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","volume":"48","author":"L Barcellini","year":"2016","unstructured":"Barcellini L, Borroni E, Brown J, Brunetti E, Campisi D, Castellotti PF, et al. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening. Eur Respir J. 2016;48:1411\u20139.","journal-title":"Eur Respir J"},{"key":"8008_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12995-017-0159-4","volume":"12","author":"EN Gallegos Morales","year":"2017","unstructured":"Gallegos Morales EN, Knierer J, Schablon A, Nienhaus A, Kersten JF. Prevalence of latent tuberculosis infection among foreign students in L\u00fcbeck, Germany tested with QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus. J Occup Med Toxicol. 2017;12:12.","journal-title":"J Occup Med Toxicol"},{"key":"8008_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12995-016-0148-z","volume":"12","author":"J Knierer","year":"2017","unstructured":"Knierer J, Gallegos Morales EN, Schablon A, Nienhaus A, Kersten JF. QFT-Plus: a plus in variability?\u2014Evaluation of new generation IGRA in serial testing of students with a migration background in Germany. J Occup Med Toxicol. 2017;12:1.","journal-title":"J Occup Med Toxicol"},{"key":"8008_CR43","doi-asserted-by":"publisher","first-page":"e00427","DOI":"10.1128\/JCM.00427-18","volume":"56","author":"JY Chien","year":"2018","unstructured":"Chien JY, Chiang HT, Lu MC, Ko WC, Yu CJ, Chen YH, et al. QuantiFERON-TB Gold Plus is a more sensitive screening tool than QuantiFERON-TB Gold In-Tube for latent tuberculosis infection among older adults in long-term care facilities. J Clin Microbiol. 2018;56:e00427\u2013518.","journal-title":"J Clin Microbiol"},{"key":"8008_CR44","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3343\/alm.2020.40.5.428","volume":"40","author":"HW Moon","year":"2020","unstructured":"Moon HW, Yi A, Yoon S, Kim H, Chung HJ, Hur M, et al. Serial assays of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in subjects exposed to patients with active tuberculosis. Ann Lab Med. 2020;40:428\u201330.","journal-title":"Ann Lab Med"},{"key":"8008_CR45","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jinf.2019.01.008","volume":"78","author":"H Zhang","year":"2019","unstructured":"Zhang H, Xin H, Wang D, Pan S, Liu Z, Cao X, et al. Serial testing of Mycobacterium tuberculosis infection in Chinese village doctors by QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold in-Tube and T-SPOT.TB. J Infect. 2019;78:305\u201310.","journal-title":"J Infect"},{"key":"8008_CR46","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.resinv.2019.07.002","volume":"57","author":"M Tsuyuzaki","year":"2019","unstructured":"Tsuyuzaki M, Igari H, Okada N, Suzuki K. Variation in interferon-\u03b3 production between QFT-Plus and QFT-GIT assays in TB contact investigation. Respir Investig. 2019;57:561\u20135.","journal-title":"Respir Investig"},{"key":"8008_CR47","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jiac.2020.11.012","volume":"27","author":"H Igari","year":"2021","unstructured":"Igari H, Takayanagi S, Yahaba M, Tsuyuzaki M, Taniguchi T, Suzuki K. Prevalence of positive IGRAs and innate immune system in HIV-infected individuals in Japan. J Infect Chemother. 2021;27:592\u20137.","journal-title":"J Infect Chemother"},{"key":"8008_CR48","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jiac.2017.09.012","volume":"24","author":"H Igari","year":"2018","unstructured":"Igari H, Ishikawa S, Nakazawa T, Oya Y, Futami H, Tsuyuzaki M, et al. Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis. J Infect Chemother. 2018;24:110\u20136.","journal-title":"J Infect Chemother"},{"key":"8008_CR49","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jiac.2019.02.018","volume":"25","author":"H Igari","year":"2019","unstructured":"Igari H, Akutsu N, Ishikawa S, Aoyama H, Otsuki K, Hasegawa M, et al. Positivity rate of interferon-\u03b3 release assays for estimating the prevalence of latent tuberculosis infection in renal transplant recipients in Japan. J Infect Chemother. 2019;25:537\u201342.","journal-title":"J Infect Chemother"},{"key":"8008_CR50","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.arbres.2020.04.011","volume":"58","author":"A Fern\u00e1ndez-Bl\u00e1zquez","year":"2022","unstructured":"Fern\u00e1ndez-Bl\u00e1zquez A, Arg\u00fcelles Men\u00e9ndez P, Sabater-Cabrera C, Garc\u00eda-Garc\u00eda JM, Asensi \u00c1lvarez V, Palacios Guti\u00e9rrez JJ. Diagnosis of tuberculous infection in immunosuppressed patients and\/or candidates for biologics using a combination of 2 IGRA tests: T-SPOT.TB\/QuantiFERON TB Gold In-Tube vs. T-SPOT.TB\/QuantiFERON TB Gold Plus. Arch Bronconeumol. 2022;58:305\u201310.","journal-title":"Arch Bronconeumol"},{"key":"8008_CR51","doi-asserted-by":"publisher","first-page":"7159485","DOI":"10.1155\/2020\/7159485","volume":"2020","author":"C Primaturia","year":"2020","unstructured":"Primaturia C, Reniarti L, Nataprawira HMN. Comparison between the interferon \u03b3 release assay-QuantiFERON Gold Plus (QFT-Plus)-and tuberculin skin test (TST) in the detection of tuberculosis infection in immunocompromised children. Pulm Med. 2020;2020:7159485.","journal-title":"Pulm Med"},{"key":"8008_CR52","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmab103","volume":"67","author":"S Surve","year":"2021","unstructured":"Surve S, Bhor V, Naukariya K, Begum S, Munne K, Tipre P, et al. Discordance between TST and QFT-TBGold Plus for latent tuberculosis screening among under-five children: an interim analysis. J Trop Pediatr. 2021;67: fmab103.","journal-title":"J Trop Pediatr"},{"key":"8008_CR53","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/ijmy.ijmy_44_21","volume":"10","author":"K Benachinmardi","year":"2021","unstructured":"Benachinmardi K, Sampath S, Rao M. Evaluation of a new interferon gamma release assay, in comparison to tuberculin skin tests and quantiferon tuberculosis goldplus for the detection of latent tuberculosis infection in children from a high tuberculosis burden setting. Int J Mycobacteriol. 2021;10:142\u20138.","journal-title":"Int J Mycobacteriol"},{"key":"8008_CR54","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ijid.2020.03.067","volume":"96","author":"FN Abdulkareem","year":"2020","unstructured":"Abdulkareem FN, Merza MA, Salih AM. First insight into latent tuberculosis infection among household contacts of tuberculosis patients in Duhok, Iraqi Kurdistan: using tuberculin skin test and QuantiFERON-TB Gold Plus test. Int J Infect Dis. 2020;96:97\u2013104.","journal-title":"Int J Infect Dis"},{"key":"8008_CR55","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jiph.2022.02.010","volume":"15","author":"N Chumpa","year":"2022","unstructured":"Chumpa N, Kawkitinarong K, Wongpiyabovorn J, Paitoonpong L, Suwanpimolkul G. Prevalence of latent tuberculosis infection among pre-clinical and clinical medical students using QuantiFERON-TB gold plus and tuberculin skin test at a teaching hospital in Thailand: a cross-sectional study. J Infect Public Health. 2022;15:400\u20135.","journal-title":"J Infect Public Health"},{"key":"8008_CR56","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1186\/s12889-021-11271-0","volume":"21","author":"S Gatechompol","year":"2021","unstructured":"Gatechompol S, Harnpariphan W, Supanan R, Suwanpimolkul G, Sophonphan J, Ubolyam S, et al. Prevalence of latent tuberculosis infection and feasibility of TB preventive therapy among Thai prisoners: a cross-sectional study. BMC Public Health. 2021;21:1206.","journal-title":"BMC Public Health"},{"key":"8008_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265036","volume":"17","author":"VN Chihota","year":"2022","unstructured":"Chihota VN, Ntshiqa T, Maenetje P, Mansukhani R, Velen K, Hawn TR, et al. Resistance to Mycobacterium tuberculosis infection among highly TB exposed South African gold miners. PLoS ONE. 2022;17: e0265036.","journal-title":"PLoS ONE"},{"key":"8008_CR58","doi-asserted-by":"publisher","first-page":"919","DOI":"10.5588\/ijtld.19.0047","volume":"23","author":"U Gurjav","year":"2019","unstructured":"Gurjav U, Ankhbat M, Ganbaatar G, Batjarga K, Ochirbat B, Baigal D, et al. Vitamin D deficiency is associated with tuberculosis infection among household contacts in Ulaanbaatar, Mongolia. Int J Tuberc Lung Dis. 2019;23:919\u201323.","journal-title":"Int J Tuberc Lung Dis"},{"key":"8008_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169539","volume":"12","author":"SK Sharma","year":"2017","unstructured":"Sharma SK, Vashishtha R, Chauhan LS, Sreenivas V, Seth D. Comparison of TST and IGRA in diagnosis of latent tuberculosis infection in a high TB-burden setting. PLoS ONE. 2017;12: e0169539.","journal-title":"PLoS ONE"},{"key":"8008_CR60","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10067-014-2817-6","volume":"35","author":"Q Ruan","year":"2016","unstructured":"Ruan Q, Zhang S, Ai J, Shao L, Zhang W. Screening of latent tuberculosis infection by interferon-\u03b3 release assays in rheumatic patients: a systemic review and meta-analysis. Clin Rheumatol. 2016;35:417\u201325.","journal-title":"Clin Rheumatol"},{"key":"8008_CR61","doi-asserted-by":"publisher","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","volume":"146","author":"D Menzies","year":"2007","unstructured":"Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146:340\u201354.","journal-title":"Ann Intern Med"},{"key":"8008_CR62","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jinf.2019.08.018","volume":"79","author":"G Sotgiu","year":"2019","unstructured":"Sotgiu G, Saderi L, Petruccioli E, Aliberti S, Piana A, Petrone L, et al. QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis. J Infect. 2019;79:444\u201353.","journal-title":"J Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08008-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08008-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08008-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T13:37:57Z","timestamp":1728740277000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08008-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8008"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08008-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2045745\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,20]]},"assertion":[{"value":"8 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors did not receive financial support and do not have conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}